Autoimmune cytopenias in common variable immunodeficiency, Front Immunol, vol.3, p.189, 2012. ,
Paraneoplastic autoimmune thrombocytopenia in solid tumors, Crit Rev Oncol Hematol, vol.81, pp.75-81, 2012. ,
A case of metastatic prostate cancer and immune thrombocytopenia, Curr Oncol, vol.24, pp.434-440, 2017. ,
Immune thrombocytopenic purpura in a patient with renal cell carcinoma, Korean J Intern Med, vol.29, pp.671-675, 2014. ,
Immune thrombocytopenia in a child with neuroblastoma. Case Rep Pediatr, p.1329489, 2017. ,
Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy, Ann Hematol, vol.95, pp.665-671, 2016. ,
Remission of newly diagnosed immune thrombocytopenia after lung cancer resection, Ann Thorac Surg, vol.97, pp.105-112, 2014. ,
Monoclonal antibodyspecific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies, Blood, vol.70, pp.1722-1728, 1987. ,
Relative efficacy of steroid therapy in immune thrombocytopenia mediated by antiplatelet GPIIbIIIa versus GPIb? antibodies, Am J Hematol, vol.87, pp.206-214, 2012. ,
The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia, Br J Haematol, vol.178, pp.302-309, 2017. ,
CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation, Clin Immunol, vol.119, pp.51-59, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00078052
A rapid and efficient platelet purification protocol for platelet gene expression studies, Methods Mol Biol, vol.788, pp.155-72, 2012. ,
Argininosuccinate synthase 1 (ASS1): a marker of unclassified hepatocellular adenoma and high bleeding risk, vol.66, pp.2016-2044, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01550711
Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count, Haematologica, vol.90, pp.829-861, 2005. ,
International consensus report on the investigation and management of primary immune thrombocytopenia, Blood, vol.115, pp.168-86, 2010. ,
Molecular mimicry and autoimmunity, J Autoimmun, vol.95, pp.100-123, 2018. ,
Molecular mimicry as a mechanism of autoimmune disease, Clin Rev Allergy Immunol, vol.42, pp.102-113, 2012. ,
Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis, J Autoimmun, vol.42, pp.39-49, 2013. ,
B cell epitope spreading: mechanisms and contribution to autoimmune diseases, Immunol Lett, vol.163, pp.56-68, 2015. ,
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab, Blood, vol.112, pp.1147-50, 2008. ,
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura, Blood, vol.112, pp.1325-1333, 2008. ,
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists, Transfusion, vol.53, pp.2807-2819, 2013. ,
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study, Br J Haematol, vol.165, pp.865-874, 2014. ,
Emerging concepts in immune thrombocytopenia, Front Immunol, vol.9, p.880, 2018. ,
Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia, J Clin Immunol, vol.31, pp.643-652, 2011. ,
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group, Blood, vol.113, pp.2386-93, 2009. ,
The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia, Blood, vol.117, pp.4190-207, 2011. ,